Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
5.43
+0.21 (4.02%)
At close: May 30, 2025, 4:00 PM
5.50
+0.07 (1.29%)
After-hours: May 30, 2025, 6:09 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $141.26 million as of May 30, 2025. Its market cap has decreased by -60.47% in one year.
Market Cap
141.26M
Enterprise Value
161.18M
1-Year Change
-60.47%
Ranking
Category
Stock Price
$5.43
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $141.26M, a decrease of -59.18%. That is a compound annual growth rate of -20.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 141.26M | 76.36% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.82B |
| Johnson & Johnson | 366.76B |
| AbbVie | 323.41B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.43B |
| Abbott Laboratories | 229.69B |
| Novartis AG | 219.70B |
| AstraZeneca | 216.88B |